Nicotinamide Adenine Dinucleotide Market Size

Nicotinamide Adenine Dinucleotide Market Size

Nicotinamide Adenine Dinucleotide Market size was recorded at over USD 488 million in 2021. Driven by changing lifestyle choices, the industry is expected to grow at around 13% CAGR from 2022 to 2030.

To get key market trends

  Download Free Sample

Nicotinamide adenine dinucleotide or NAD is attaining positive attention due to its varied health benefits, such as improving athletic performance, reducing chronic fatigue syndrome, managing high cholesterol, treating depression, controlling high blood pressure, helping in anti-aging, maintaining the effects of alcohol on the liver, and more. Mounting utilization and demand from pharmaceuticals are likely to foster nicotinamide adenine dinucleotide market growth over 2022-2030.

Consistent R&D initiatives to improve the effectiveness of NADH or NAD+ on the metabolism to offer therapeutic intervention in inflammatory disorders are contributing substantially to the product adoption rate. For instance, a May 2022 study on NAD metabolism in the immune response, autoimmunity, and inflammageing, funded by the Spanish Ministry of Science and Innovation, concluded that stimuli timing, dosage, and the cellular metabolic state, together with the form of NAD+ supplementation result in the increased global level of NAD+.

Government regulations on dosage may restrain industry progression

Stringent government norms regarding dosage to prevent adverse health effects are foreseen to restrain industry expansion. As NAD works differently depending on the dosage and therapy, the government agencies of various countries have only given it OTC categorization. Nonetheless, advancements in food grade NAD in the form of immunity boosters are set to proliferate the demand for nicotinamide adenine dinucleotide supplements, thereby enabling companies to overcome this issue.